These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 33749772)

  • 1. Centralized repeated resectability assessment of patients with colorectal liver metastases during first-line treatment: prospective study.
    Isoniemi H; Uutela A; Nordin A; Lantto E; Kellokumpu I; Ovissi A; Kosunen J; Kallio R; Soveri LM; Salminen T; Ålgars A; Lamminmäki A; Halonen P; Ristamäki R; Räsänen J; Karjula H; Vaalavuo Y; Lavonius M; Osterlund P
    Br J Surg; 2021 Jul; 108(7):817-825. PubMed ID: 33749772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and management of patients with colorectal cancer and synchronous and metachronous colorectal metastases: a population-based study.
    Väyrynen V; Wirta EV; Seppälä T; Sihvo E; Mecklin JP; Vasala K; Kellokumpu I
    BJS Open; 2020 Aug; 4(4):685-692. PubMed ID: 32543788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study.
    Osterlund P; Salminen T; Soveri LM; Kallio R; Kellokumpu I; Lamminmäki A; Halonen P; Ristamäki R; Lantto E; Uutela A; Osterlund E; Ovissi A; Nordin A; Heervä E; Lehtomäki K; Räsänen J; Murashev M; Aroviita L; Jekunen A; Lindvall-Andersson R; Nyandoto P; Kononen J; Lepistö A; Poussa T; Muhonen T; Ålgars A; Isoniemi H;
    Lancet Reg Health Eur; 2021 Apr; 3():100049. PubMed ID: 34557799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curative-intent treatment of recurrent colorectal liver metastases: A comparison between ablation and resection.
    Dupré A; Jones RP; Diaz-Nieto R; Fenwick SW; Poston GJ; Malik HZ
    Eur J Surg Oncol; 2017 Oct; 43(10):1901-1907. PubMed ID: 28888801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver resection surgery compared with thermal ablation in high surgical risk patients with colorectal liver metastases: the LAVA international RCT.
    Davidson B; Gurusamy K; Corrigan N; Croft J; Ruddock S; Pullan A; Brown J; Twiddy M; Birtwistle J; Morris S; Woodward N; Bandula S; Hochhauser D; Prasad R; Olde Damink S; Coolson M; Laarhoven KV; de Wilt JH
    Health Technol Assess; 2020 Apr; 24(21):1-38. PubMed ID: 32370822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma.
    Shah SA; Haddad R; Al-Sukhni W; Kim RD; Greig PD; Grant DR; Taylor BR; Langer B; Gallinger S; Wei AC
    J Am Coll Surg; 2006 Mar; 202(3):468-75. PubMed ID: 16500252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of microscopic incomplete resection (R1) of colorectal liver metastases in the era of neoadjuvant chemotherapy.
    Ayez N; Lalmahomed ZS; Eggermont AM; Ijzermans JN; de Jonge J; van Montfort K; Verhoef C
    Ann Surg Oncol; 2012 May; 19(5):1618-27. PubMed ID: 22006375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeat hepatic resection for colorectal liver metastases.
    Adair RA; Young AL; Cockbain AJ; Malde D; Prasad KR; Lodge JP; Toogood GJ
    Br J Surg; 2012 Sep; 99(9):1278-83. PubMed ID: 22864889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical management of patients with colorectal cancer and simultaneous liver and lung metastases.
    Andres A; Mentha G; Adam R; Gerstel E; Skipenko OG; Barroso E; Lopez-Ben S; Hubert C; Majno PE; Toso C
    Br J Surg; 2015 May; 102(6):691-9. PubMed ID: 25789941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trial.
    Garlipp B; Gibbs P; Van Hazel GA; Jeyarajah R; Martin RCG; Bruns CJ; Lang H; Manas DM; Ettorre GM; Pardo F; Donckier V; Benckert C; van Gulik TM; Goéré D; Schoen M; Pratschke J; Bechstein WO; de la Cuesta AM; Adeyemi S; Ricke J; Seidensticker M
    Br J Surg; 2019 Dec; 106(13):1837-1846. PubMed ID: 31424576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases.
    Capussotti L; Muratore A; Mulas MM; Massucco P; Aglietta M
    Br J Surg; 2006 Aug; 93(8):1001-6. PubMed ID: 16739103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases.
    Elias D; Ouellet JF; Bellon N; Pignon JP; Pocard M; Lasser P
    Br J Surg; 2003 May; 90(5):567-74. PubMed ID: 12734864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival outcomes of liver metastasectomy in colorectal cancer cases: a single-center analysis in Turkey.
    Cokmert S; Ellidokuz H; Demir L; Fuzun M; Astarcioglu I; Aslan D; Yilmaz U; Oztop I
    Asian Pac J Cancer Prev; 2014; 15(13):5195-200. PubMed ID: 25040974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resectability, conversion, metastasectomy and outcome according to RAS and BRAF status for metastatic colorectal cancer in the prospective RAXO study.
    Uutela A; Osterlund E; Halonen P; Kallio R; Ålgars A; Salminen T; Lamminmäki A; Soveri LM; Ristamäki R; Lehtomäki K; Stedt H; Heervä E; Muhonen T; Kononen J; Nordin A; Ovissi A; Kytölä S; Keinänen M; Sundström J; Nieminen L; Mäkinen MJ; Kuopio T; Ristimäki A; Isoniemi H; Osterlund P
    Br J Cancer; 2022 Sep; 127(4):686-694. PubMed ID: 35610367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?
    Bakalakos EA; Burak WE; Young DC; Martin EW
    Am J Surg; 1999 Jan; 177(1):2-6. PubMed ID: 10037299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases.
    Angelsen JH; Viste A; Løes IM; Eide GE; Hoem D; Sorbye H; Horn A
    World J Surg Oncol; 2015 Dec; 13():328. PubMed ID: 26631156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRAF mutation is not associated with an increased risk of recurrence in patients undergoing resection of colorectal liver metastases.
    Bachet JB; Moreno-Lopez N; Vigano L; Marchese U; Gelli M; Raoux L; Truant S; Laurent C; Herrero A; Le Roy B; Deguelte Lardiere S; Passot G; Hautefeuille V; De La Fouchardiere C; Artru P; Ameto T; Mabrut JY; Schwarz L; Rousseau B; Lepère C; Coriat R; Brouquet A; Sa Cunha A; Benoist S
    Br J Surg; 2019 Aug; 106(9):1237-1247. PubMed ID: 31183866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival after lung metastasectomy in colorectal cancer patients with previously resected liver metastases.
    Gonzalez M; Robert JH; Halkic N; Mentha G; Roth A; Perneger T; Ris HB; Gervaz P
    World J Surg; 2012 Feb; 36(2):386-91. PubMed ID: 22167262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resection of Concomitant Hepatic and Extrahepatic Metastases from Colorectal Cancer - A Worthwhile Operation?
    Diaconescu A; Alexandrescu S; Ionel Z; Zlate C; Grigorie R; Brasoveanu V; Hrehoret D; Ciurea S; Botea F; Tomescu D; Droc G; Croitoru A; Herlea V; Boros M; Grasu M; Dumitru R; Toma M; Ionescu M; Vasilescu C; Popescu I
    Chirurgia (Bucur); 2017; 112(6):673-682. PubMed ID: 29288609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases.
    Brandi G; Derenzini E; Falcone A; Masi G; Loupakis F; Pietrabissa A; Pinna AD; Ercolani G; Pantaleo MA; Di Girolamo S; Grazi GL; de Rosa F; Biasco G
    Clin Colorectal Cancer; 2013 Sep; 12(3):188-94. PubMed ID: 23773458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.